市場調査レポート

商品コード

1085497

トランスクリプトミクス技術の世界市場：技術別、アプリケーション別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

Transcriptomics Technologies Market, By Technology, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: 2022年05月27日 | 発行: Coherent Market Insights

| ページ情報: 英文 150 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 700,920円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,090,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,557,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

マイクロアレイの承認や新製品の発売の増加は、予測期間中のトランスクリプトミクス技術市場の成長を促進すると予想されます。さらに、心血管疾患の増加は、トランスクリプトミクス技術市場企業に有利な成長機会をもたらすと予想されます。

当レポートでは、世界のトランスクリプトミクス技術市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

Transcriptomics the study of structures and functions of transcript molecules. Transcripts comprise all types of ribonucleic acid (RNA) molecules namely, messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding RNA molecules. Increasing approval and new product launch of microarrays is expected to propel growth of the global transcriptomics technologies market over the forecast period. Furthermore, Increasing prevalence of cardiovascular diseases is expected to offer lucrative growth opportunities for players in the global transcriptomics technologies market.

Key features of the study:

This report provides in-depth analysis of the Global Transcriptomics Technologies market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Transcriptomics Technologies market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Ethicon, Inc. (Johnson & Johnson), Covidien Plc. (Medtronic Plc.), B. Braun Melsungen AG, Medicon EG, Erbe Elektromedizin GmbH, Conmed Corporation, Carefusion, and Cardinal Health.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Transcriptomics Technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Transcriptomics Technologies market

Detailed Segmentation:

Global Transcriptomics Technologies Market, By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
Global Transcriptomics Technologies Market, By Application:
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
Global Transcriptomics Technologies Market, By Region:
- North America
  - By Technology:
  - Microarrays
  - PCR
  - Gene Regulation Technologies
  - Next Generation Sequencing
  - By Application
  - Clinical Diagnostics
  - Drug Discovery & Research
  - Bioinformatics
  - Comparative Transcriptomics
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Technology:
  - Microarrays
  - PCR
  - Gene Regulation Technologies
  - Next Generation Sequencing
  - By Application
  - Clinical Diagnostics
  - Drug Discovery & Research
  - Bioinformatics
  - Comparative Transcriptomics
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Technology:
  - Microarrays
  - PCR
  - Gene Regulation Technologies
  - Next Generation Sequencing
  - By Application
  - Clinical Diagnostics
  - Drug Discovery & Research
  - Bioinformatics
  - Comparative Transcriptomics
  - By Country
  - U.K.
  - Germany
  - France
  - Spain
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Technology:
  - Microarrays
  - PCR
  - Gene Regulation Technologies
  - Next Generation Sequencing
  - By Application
  - Clinical Diagnostics
  - Drug Discovery & Research
  - Bioinformatics
  - Comparative Transcriptomics
  - By Country
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Technology:
  - Microarrays
  - PCR
  - Gene Regulation Technologies
  - Next Generation Sequencing
  - By Application
  - Clinical Diagnostics
  - Drug Discovery & Research
  - Bioinformatics
  - Comparative Transcriptomics
  - By Country
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - By Technology:
  - Microarrays
  - PCR
  - Gene Regulation Technologies
  - Next Generation Sequencing
  - By Application
  - Clinical Diagnostics
  - Drug Discovery & Research
  - Bioinformatics
  - Comparative Transcriptomics
  - By Country
  - North Africa
  - Central Africa
  - South Africa
Company Profiles
- Affymetrix, Inc. *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd
- Life Technologies Corporation
- LC Sciences, LLC
- Qiagen N.V.
"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By Country
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions
Impact of COVID19 on the market

4. Global Transcriptomics Technologies Market, By Technology, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Microarrays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
PCR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Gene Regulation Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Next Generation Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Transcriptomics Technologies Market, By Application, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Drug Discovery & Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Bioinformatics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Comparative Transcriptomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Transcriptomics Technologies Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Technology, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Technology, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Technology, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Technology, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Technology, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Technology, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa

7. Competitive Landscape

Company Profiles
- Affymetrix, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Danaher Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Illumina, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Life Technologies Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- LC Sciences, LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Qiagen N.V.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies

8. Section

References
Research Methodology
About us and Sales Contact

トランスクリプトミクス技術の世界市場：技術別、アプリケーション別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

Transcriptomics Technologies Market, By Technology, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学、規制、および動向分析

第4章世界のトランスクリプトミクス技術市場：技術別（100万米ドル）（2017年～2028年）

第5章世界のトランスクリプトミクス技術市場：アプリケーション別（100万米ドル）（2017年～2028年）

第6章世界のトランスクリプトミクス技術市場：地域別（100万米ドル）（2017年～2028年）

第7章競合情勢

第8章セクション

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Transcriptomics Technologies Market, By Technology, 2017 - 2028, (US$ Mn)

5. Global Transcriptomics Technologies Market, By Application, 2017 - 2028, (US$ Mn)

6. Global Transcriptomics Technologies Market, By Region, 2017 - 2028, (US$ Mn)

7. Competitive Landscape

8. Section

トランスクリプトミクス技術の世界市場：技術別、アプリケーション別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

Transcriptomics Technologies Market, By Technology, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場の展望

第3章 市場力学、規制、および動向分析

第4章 世界のトランスクリプトミクス技術市場：技術別（100万米ドル）（2017年～2028年）

第5章 世界のトランスクリプトミクス技術市場：アプリケーション別（100万米ドル）（2017年～2028年）

第6章 世界のトランスクリプトミクス技術市場：地域別（100万米ドル）（2017年～2028年）

第7章 競合情勢

第8章 セクション

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Transcriptomics Technologies Market, By Technology, 2017 - 2028, (US$ Mn)

5. Global Transcriptomics Technologies Market, By Application, 2017 - 2028, (US$ Mn)

6. Global Transcriptomics Technologies Market, By Region, 2017 - 2028, (US$ Mn)

7. Competitive Landscape

8. Section

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学、規制、および動向分析

第4章世界のトランスクリプトミクス技術市場：技術別（100万米ドル）（2017年～2028年）

第5章世界のトランスクリプトミクス技術市場：アプリケーション別（100万米ドル）（2017年～2028年）

第6章世界のトランスクリプトミクス技術市場：地域別（100万米ドル）（2017年～2028年）

第7章競合情勢

第8章セクション